Engineered bacteria for augmented<i>in situ</i>tumor vaccination
Xinyuan Shen, Chaojie Zhu, Xutao Liu, Hanqi Zheng, Qing Wu, Jijin Xie, Hao Huang, Ziyan Liao, Jiaqi Shi, Kewang Nan, Junxia Wang, Xu‐Ming Mao, Zhen Gu, Hongjun Li
Abstract
Engineered bacteria can be leveraged for in situ tumor vaccinations with their tumor-targeting ability and adjuvanticity. Engineering strategies like chemical modification, nanotechnology, and genetic engineering improve their safety and efficacy.
Topics & Concepts
In situBacteriaComputational biologyVaccinationMicrobiologyChemistryVirologyBiologyGeneticsOrganic chemistryCancer Research and TreatmentsBacteriophages and microbial interactionsVirus-based gene therapy research